Zamknij

PL - PL


Please select a country and, if applicable, a language.

Przegląd artykułów

Probiotics: quality matters


Probiotics are a generally safe treatment option and have been evaluated positively for several conditions by the Cochrane Collaboration. However, they must have adequate compositional quality and be ...

Do artykułu
Autor: Paolo Pellegrino, MD i Marcos Perez III., MDEFSM: 2022;2:220086DOI: 10.52778/efsm.22.0086Data: 10.04.2022

Stress symptoms: Evidence supporting a phytopharmaceutical product with new marketing authorisation…


Phytotherapeutics are used in many countries to treat stress symptoms such as mild sleep disorders, anxiety, increased irritability, tension and nervous restlessness. An established combination prepar ...

Do artykułu
Autor: Christiane Kolb, PhD i Heba Aziz-Kalbhenn, PhDEFSM: 2022;2:220039DOI: 10.52778/efsm.22.0039Data: 27.02.2022

Study confirms the effect of a supplement on the micronutrient content of breast milk


Even in countries with a high standard of living, the intake of essential nutrients by breast-feeding women is often inadequate – with potentially negative effects on the development of their baby. A ...

Do artykułu
Autor: Jens Seibel, LeverkusenEFSM: 2022;2:220037DOI: 10.52778/efsm.22.0037Data: 21.02.2022

Intranasal triamcinolone acetonide effectively improves nasal symptoms and quality of life in …


Allergic rhinitis is a common problem with increasing prevalence. Two recent publications demonstrate that intranasal triamcinolone acetonide is an effective treatment that progressively improves nasa ...

Do artykułu
Autor: Mohamed Amessou, PhD, Elizaveta Leshcheva, PharmD, Aleksandr Maslakov, MD, PhD i Palak Venkataraman, PharmDEFSM: 2022;2:220022DOI: 10.52778/efsm.22.0022Data: 05.02.2022

Update on the antibiotic treatment of uncomplicated skin abscesses


Cutaneous abscesses are often caused by S. aureus. The most important therapeutic measure is drainage of the accumulated pus. Although the clinical benefit from additionally administering oral antibio ...

Do artykułu
Autor: Annette Sethmann, PhDEFSM: 2022;2:220035DOI: 10.52778/efsm.22.0035Data: 31.01.2022

Probiotics can prevent drug-induced gastrointestinal symptoms


Probiotics such as Bacillus clausii reduce the occurrence of gastrointestinal side effects of commonly used medications such as antibiotics and proton pump inhibitors in placebo-controlled randomized ...

Do artykułu
Autor: Manuel Plomer, PhD i Marcos III Perez, MDEFSM: 2022;2:220009DOI: 10.52778/efsm.22.0009Data: 26.01.2022

The probiotic Bacillus clausii is an effective treatment of acute diarrhea in children


A systematic review and meta-analysis confirms that the probiotic Bacillus clausii is an effective treatment for acute diarrhea in childhood. It shortens the duration of diarrhea and associated hospit ...

Do artykułu
Autor: Marcos III Perez, MD i Dorothea M. Greifenberg, PhDEFSM: 2022;2:220003DOI: 10.52778/efsm.22.0003Data: 21.01.2022

Niezbędne fosfolipidy w chorobach stłuszczeniowych wątroby


Wątroba jest ważnym narządem metabolizmu i układu odpornościowego. Nadmierna podaż węglowodanów lub nadmierne spożywanie alkoholu może wywoływać procesy zapalne i prowadzić do rozwoju choroby stłuszcz ...

Do artykułu
Autor: Assoc. Prof. Peter Minárik, MD, PhD, MSc i Eva Koscova MD, PhD, MBAEFSM: 2022;2:220019DOI: 10.52778/efsm.22.0019Data: 19.01.2022

Better understanding of “21st century headache” via real-world data


Throughout the world, headache is one of the main causes of limitations in daily life and/or unfitness to work. 50% of sufferers never consult a doctor and instead turn to self-medication. A recently ...

Do artykułu
Autor: Luminita Constantin, MD, Marion Eberlin, PhD, Iva Igracki Turudic, MD i Martin C. Michel, MDEFSM: 2022;2:220001DOI: 10.52778/efsm.22.0001Data: 17.01.2022

Bisakodyl: obszerne wyniki wskazują na skuteczność i bezpieczeństwo stosowania w zaparciach


Po raz pierwszy od wydania zezwolenia na wprowadzenie bisakodylu do obrotu w latach 50. aktualny przegląd dostarczył szczegółowego podsumowania danych farmakologicznych i  ...

Do artykułu
Autor: Sabine Landes, PhD, Marion Eberlin, PhD i Robert Lange, PhDEFSM: 2021;1:210343DOI: 10.52778/efsm.21.0343 Data: 06.12.2021